Cytokinetics, Inc. (CYTK)
75.85
-2.79
(-3.55%)
USD |
NASDAQ |
May 15, 16:00
75.87
+0.02
(+0.03%)
After-Hours: 07:57
Cytokinetics Shareholders Equity (Quarterly) : -826.57M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 20.07B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Sarepta Therapeutics, Inc. | 1.505B |
| Moderna, Inc. | 7.408B |
| Revolution Medicines, Inc. | 1.500B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.273B |
| Total Liabilities (Quarterly) | 2.100B |
| Debt to Equity Ratio | -1.559 |
| Current Ratio | 4.214 |
| Net Debt Paydown Yield | -1.22% |